Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Lamont

Showing results (131-140 of 146) with videos related to

Pageof 15
Sort By:
JCO Clinical Cancer Informatics|January 6, 2023
Historic Clinical Trial External Control Arm Provides Actionable GEN-1 Efficacy Estimate Before a Randomized TrialXiang Yin, Ruthanna Davi, Elizabeth B Lamont, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2012
Survival of older patients with cancer in the Veterans Health Administration versus fee-for-service MedicareMary Beth Landrum, Nancy L Keating, Elizabeth B Lamont, et al.
Journal of the National Cancer Institute|September 18, 2003
Is patient travel distance associated with survival on phase II clinical trials in oncology?Elizabeth B Lamont, Davinder Hayreh, Kate E Pickett, et al.
Journal of Medicinal Chemistry|November 12, 1993
Inhibitors of cholesterol biosynthesis. 1. 3,5-Dihydroxy-7-(N-imidazolyl)-6-heptenoates and -heptanoates, a novel series of HMG-CoA reductase inhibitorsC Chan, E J Bailey, C D Hartley, et al.
Journal of Medicinal Chemistry|November 26, 1993
Synthesis and anti-HIV-1 activity of a series of imidazo[1,5-b]pyridazinesD G Livermore, R C Bethell, N Cammack, et al.
Journal of the National Cancer Institute|November 30, 2014
Generalizability of trial results to elderly Medicare patients with advanced solid tumors (Alliance 70802)Elizabeth B Lamont, Richard L Schilsky, Yulei He, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2014
Genotyping lung cancer is an investment in the futureChristopher G Azzoli, Jeffrey Engelman, Panos Fidias, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 2023
Utility-value intervention promotes persistence and diversity in STEMMichael W Asher, Judith M Harackiewicz, Patrick N Beymer, et al.
Annals of Internal Medicine|June 8, 2011
Quality of care for older patients with cancer in the Veterans Health Administration versus the private sector: a cohort studyNancy L Keating, Mary Beth Landrum, Elizabeth B Lamont, et al.
Journal of Personality and Social Psychology|October 5, 2023
A prosocial value intervention in gateway STEM coursesJudith M Harackiewicz, Cameron A Hecht, Michael W Asher, et al.
Pageof 15

Showing results (131-140 of 146) with videos related to

Sort By:
Pageof 15
JCO Clinical Cancer Informatics|January 6, 2023
Historic Clinical Trial External Control Arm Provides Actionable GEN-1 Efficacy Estimate Before a Randomized TrialXiang Yin, Ruthanna Davi, Elizabeth B Lamont, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2012
Survival of older patients with cancer in the Veterans Health Administration versus fee-for-service MedicareMary Beth Landrum, Nancy L Keating, Elizabeth B Lamont, et al.
Journal of the National Cancer Institute|September 18, 2003
Is patient travel distance associated with survival on phase II clinical trials in oncology?Elizabeth B Lamont, Davinder Hayreh, Kate E Pickett, et al.
Journal of Medicinal Chemistry|November 12, 1993
Inhibitors of cholesterol biosynthesis. 1. 3,5-Dihydroxy-7-(N-imidazolyl)-6-heptenoates and -heptanoates, a novel series of HMG-CoA reductase inhibitorsC Chan, E J Bailey, C D Hartley, et al.
Journal of Medicinal Chemistry|November 26, 1993
Synthesis and anti-HIV-1 activity of a series of imidazo[1,5-b]pyridazinesD G Livermore, R C Bethell, N Cammack, et al.
Journal of the National Cancer Institute|November 30, 2014
Generalizability of trial results to elderly Medicare patients with advanced solid tumors (Alliance 70802)Elizabeth B Lamont, Richard L Schilsky, Yulei He, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2014
Genotyping lung cancer is an investment in the futureChristopher G Azzoli, Jeffrey Engelman, Panos Fidias, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 2023
Utility-value intervention promotes persistence and diversity in STEMMichael W Asher, Judith M Harackiewicz, Patrick N Beymer, et al.
Annals of Internal Medicine|June 8, 2011
Quality of care for older patients with cancer in the Veterans Health Administration versus the private sector: a cohort studyNancy L Keating, Mary Beth Landrum, Elizabeth B Lamont, et al.
Journal of Personality and Social Psychology|October 5, 2023
A prosocial value intervention in gateway STEM coursesJudith M Harackiewicz, Cameron A Hecht, Michael W Asher, et al.
Pageof 15